Clinical trial
Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses
NCT00284739 · Kaiser Permanente, Other · Completed
Key facts
| NCT number | NCT00284739 |
|---|---|
| Title | Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses |
| Official title | Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses |
| Lead sponsor | Kaiser Permanente, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Abdominal Abscess, Pelvic Abscess |
| Intervention type | Drug, Other |
| Interventions | Alteplase, saline |
| Enrollment | 20 |
| Start date | Feb 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Feb 1, 2006 |
| Last update posted | Feb 26, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: